CLENE INC. (CLNN)
Clene Announces $7 Million Underwritten Offering of Common Stock
Clene Announces $7 Million Underwritten Offering of Common Stock
Merck Completes Acquisition of Terns Pharmaceuticals, Inc.
Foresight to Strengthen Intelligence for Defense Autonomous Systems Through Collaboration
Lithium Ionic Responds to Shareholder Requisition
Foresight to Strengthen Intelligence for Defense Autonomous Systems Through Collaboration
A2Z Cust2Mate Strengthens Retail Media Position as Advertisers Tap Smart Carts for In-Store Reach
Victoria’s Secret & Co. Board Comments on BBRC’s Distracting Proxy Contest; Underscores Significant Outperformance and Board’s Commitment to Acting in the Best Interest of Shareholders
MaxLinear Showcases Panther to Accelerate AI Inference and Data Movement Efficiency in Datacenters at Dell Tech World ‘26
Ocugen Provides Business Update with First Quarter 2026 Financial Results
Oragenics Activates Second Site in Phase IIa Clinical Trial of ONP-002 for Concussion and Mild Traumatic Brain Injury.